Evaluation of centrosome abnormalities and p53 inactivation in chemical induced hepatocellular carcinogenesis

Neoplasma

Volumn 56, Issue 2, 2009, Pages 169-176

  Chen, Y ^a,b   Kong, Q ^b,c  

^a HENAN INSTITUTE OF SCIENCE AND TECHNOLOGY   (China)

^b SHANDONG UNIVERSITY   (China)

^c Shandong Lanjin Pharmaceutical Co Ltd   (China)

Author keywords

Cell proliferation; Centrosome; Hepatocellular carcinoma; p53

Indexed keywords

DIETHYLNITROSAMINE; PROTEIN P53;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CARCINOGENESIS; CELL CYCLE; CELL ORGANELLE; CELL PROLIFERATION; CENTROSOME; CHROMOSOMAL INSTABILITY; CONTROLLED STUDY; IMMUNOASSAY; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; INFLAMMATION; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; WESTERN BLOTTING; ANIMAL; CHEMICALLY INDUCED DISORDER; LIVER TUMOR; PATHOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT; ULTRASTRUCTURE;

ANIMALS; CELL PROLIFERATION; CENTROSOME; LIVER NEOPLASMS, EXPERIMENTAL; MALE; RATS; RATS, SPRAGUE-DAWLEY; TUMOR SUPPRESSOR PROTEIN P53;

EID: 65649107332     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: 10.4149/neo_2009_02_169     Document Type: Article

References (35)

1. NIU MY, MILLS JC, NACHMIAS VT. Development of polarity in human erythroleukemia cells: roles of membrane ruffling and the centrosome. Cell Motil Cytoskeleton 1997; 36: 203-215. doi:10.1002/(SICI)1097-0169(1997)36:3〈203: :AIDCM1〉 3.0.Co;2-8 PMid:9067616
2. YVON AM, WALKER JW, DANOWSKI B, et al. Centrosome reorientation in wound-edge cells is cell type specific. Mol Biol Cell 2002; 13: 1871-1880. doi:10.1091/mbc.01-11-0539 PMid:12058055 PMCid:117610
3. Bornens, M. Centrosome composition and microtubule anchoring mechanisms. Curr Opin Cell Biol 2002; 14: 25-34. doi:10.1016/S0955-0674(01)00290-3 PMid:11792541 (Pubitemid 34131653)
4. Jackman M, Lindon C, NIGG EA, et al. Active cyclin B1Cdk1 first appears on centrosomes in prophase. Nat Cell Biol 2003; 5: 143-148. doi:10.1038/ncb918 PMid:12524548 (Pubitemid 36204196)
5. Doxsey S, Macollum D, Therkauf W. Centrosomes in cellular regulation. Annu Rev Cell Dev Biol 2005; 21:411-434. doi:10.1146/annurev.cellbio.21.122303. 120418 PMid:16212501
6. Boveri T. Zur Frage der Entstehung maligner Tumoren. Jena: G. Fischer; 1914.
7. Kawamura K, Moriyama M, Shiba N, et al. Centrosome hyperamplification and chromosomal instability in bladder cancer. Eur Urol 2003, 43: 505-515. doi:10.1016/ S0302-2838(03)00056-63 PMid:12705995 (Pubitemid 36528437)
8. PIHAN GA, PUROHIT A, WALLACE J, et al. Centrosome defects and genetic instability in malignant tumors. Cancer Res 1998; 58: 3974-3985. (Pubitemid 28405657)
9. Neben K, Giesecke C, Schwezer S, et al. Centrosome aberrations in acute myeloid leukemia are correlated with cytogenetic risk profile. Blood 2003; 101: 289-291. doi:10.1182/blood-2002-04-1188 PMid:12393441 (Pubitemid 36025920)
10. Nakajima T, Moriguchi M, Mitsumoto Y, et al. Centrosome aberration accompanied with p53 mutation can induce genetic instability in hepatocellular carcinoma. Mod Pathol 2004; 17: 722-727. doi:10.1038/modpathol.3800115 PMid:15044920 (Pubitemid 38715497)
11. NIGG EA. Centrosome aberrations: cause or consequence of cancer progression? Nat Rev Cancer 2002; 2: 815-825. doi:10.1038/nrc924 PMid:12415252
12. Mikul K, Delaval B, Kaldis P, et al. loss of centrosome integrity induces p38-p53-p21-dependent G1-S arrest. Nat Cell Biol 2007; 9: 160-170. doi:10.1038/ncb1529 PMid:17330329 (Pubitemid 46420858)
13. Kan Q, Jinno S, Yamamoto H, et al. Chemical DNA damage activates p21(WAF1/CIP1)-dependent intra-S checkpoint. FEBS Lett 2007; 581(30):5879-5884. doi:10.1016/j.febslet. 2007.11.075 PMid:18067863 (Pubitemid 50012821)
14. Ohshima H, Bartch H. Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis. Mutat Res 1994; 305: 253-264. doi:10.10 16/0027-5107(94)90245-90253 (Pubitemid 24082901)
15. GRISHAM JW. Interspecies comparison of liver carcinogenesis: implications for cancer risk assessment. Carcinogenesis 1997; 18: 59-81. doi:10.1093/carcin/18.1.59 PMid:9054591 (Pubitemid 28134618)
16. Solt D, Farber E. New principle for the analysis of chemical carcinogenesis. Nature 1976; 263 (5580): 701-703. doi:10.1038/263701a0
17. PIHAN GA, PUROHIT A, WALLACE J, et al. Centrosome defects can account for cellular and genetic changes that characterize prostate cancer progression. Cancer Res 2001; 61: 212-2219.
18. Tritarelli A, Orichio E, Ciciarello M, et al. p53 localization at centrosomes during mitosis and postmitotic checkpoint are ATM-dependent and require serine 15 phosphorylation. Mol Biol Cell 2004; 15: 3751-3758. doi:10.1091/mbc. E03-12-0900 PMid:15181149 PMCid:491834 (Pubitemid 38989712)
19. Shinmura K, BENNETT RA, TARAPORE P, et al. Direct evidence for the role of centrosomally localized p53 in the regulation of centrosome duplication. Oncogene 2007; 26: 2939-2944. doi:10.1038/sj.onc.1210085 PMid:17072342 (Pubitemid 46701435)
20. Fukasawa K, Choi T, Kuriyama R, et al. Abnormal centrosome amplification in the absence of p53. science 1996; 271 (5256): 1744-1747. doi:10.1126/science. 271.5256.1744 PMid:8596939
21. D'ASSORO AB, BUSBY R, ACU ID, et al. Impaired p53 function leads to centrosome amplification, acquired Eralpha phenotypic heterogeneity and distant metastases in breast cancer MCF-7 xenografts. Oncogene 2008; 27: 3901-3911. doi:10.1038/onc.2008.18 PMid:18264135 PMCid:2526020
22. Kawamura K, Izumi H, MA Z, et al. Induction of centrosome amplification and chromosome instability in human bladder cancer cells by p53 mutation and cyclin E overexpression. Cancer Res 2004; 64: 4800-4809. doi:10.1158/0008-5472. CAN-03-3908 PMid:15256449 (Pubitemid 38924523)
23. SQUIRE RA, LEVITT MH. Report of a workshop in classification of specific hepatocellular lesions in rats. Cancer Res 1975; 35: 3214-3223.
24. Lotschutz D, Jennewein M, Pahl S, et al. Polyploidization and centrosome hyperamplification in inflammatory bronchi. Inflamm Res 2002; 51: 416-422. doi:10.1007/PL00000323 PMid:12234059 (Pubitemid 34899028)
25. MILLIKEN EL, LOZADZ KL, JOHNSON E, et al. Ovarian hyperstimulation induces centrosome amplification and aneuploid mammary tumors independently of alterations in p53 in a transgenic mouse model of breast cancer. Oncogen 2007; 27: 1759-1766.
26. Meraidi P, Honda R, NIGG EA. Aurora-A overexpression reveals tetraploidization as a major route to centrosome amplification in p53-/- cells. EMBO J 2002; 21: 483-492. doi:10.1093/ emboj/21.4.483 PMid:11847097 PMCid:125866 (Pubitemid 34174030)
27. Fan T, Yan Q, Huang J, et al. Lsh-deficient murine embryonal fibroblasts show reduced proliferation with signs of abnormal mitosis. Cancer Res 2003; 63: 4677-4683. (Pubitemid 36951047)
28. Ssato N, Mizumoto K, Nakamura M, et al. Radiation-induced centrosome overduplication and multiple mitotic spindles in human tumor cells. Exp Cell Res 2000; 255: 321-326. doi:10.1006/excr.1999.4797 PMid:10694447 (Pubitemid 30143865)
29. Tessitore L. Apoptosis and cell proliferation are involved in the initiation of liver carcinogenesis by a subnecrogenic dose of diethylnitrosamine in refed rats. J Nutr 2000; 130: 104-110. (Pubitemid 30032838)
30. ANDERSON CW. DNA damage and the DNA-activated protein kinase. Trends Biochem Sci 1993; 18: 433-437. doi:10.1016/0968-0004(93)90144-C PMid:8291090 (Pubitemid 23316628)
31. Garner E, Raj K. Protective mechanisms of p53-p21-prb proteins against DNA damage induced cell death. Cell Cycle 2008; 7: 277-282.
32. Duensing S, Munger K. Human papillomaviruses and centrosome duplication errors: modeling the origins of genomic instability. Oncogene 2002; 21: 6241-6248. doi:10.1038/ sj.onc.1205709 PMid:12214255
33. Duensing S, Munger K. The human papillomavirus type 16 E6 and E7 oncoproteins independently induce numerical and structural chromosome instability. Cancer Res 2002; 62: 7075-7082. (Pubitemid 35424103)
34. Duensing S. A tentative classification of centrosome abnormalities in cancer. Cell Biol Int 2005; 29: 352-359. doi:10.1016/j. cellbi.2005.03.005 PMid:15890539 (Pubitemid 40981993)
35. Dutertre S, Hamard-Peron E, CREMET JY, et al. The absence of p53 aggravates polyploidy and centrosome number abnormality induced by Aurora-C overexpression. Cell Cycle 2005; 4: 1783-1787. (Pubitemid 41827325)